CoChat
Sign Up
Cited by 33

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Single-cell approaches identify the molecular network driving malignant hematopoietic stem cell self-renewal

Shepherd, Mairi S., Li, Juan, Wilson, Nicola K., Oedekoven, Caroline A., Li, Jiangbing, Belmonte, Miriam, Fink, Juergen, Prick, Janine C. M., Pask, Dean C., Hamilton, Tina L., Loeffler, Dirk, Rao, Anjana, Schröder, Timm, Göttgens, Berthold, Green, Anthony R., Kent, David G.·2018·Blood
DOI 10.1182/blood-2017-12-821066
Open this paper in CoChat — free account

Abstract

Key Points: Single-cell approaches identify regulators of malignant HSC self-renewal. Identification of novel roles for Bmi1, Pbx1, and Meis1 in myeloproliferative neoplasms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2017-12-821066

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 39

  1. Bryder, 2006, Hematopoietic stem cells: the paradigmatic tissue-specific stem cell, Am J Pathol, 169, 338, 10.2353/ajpath.2006.060312 · DOI
  2. Prick, 2014, Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasms, Exp Hematol, 42, 841, 10.1016/j.exphem.2014.07.268 · DOI
  3. Jamieson, 2008, Miscreant myeloproliferative disorder stem cells, Leukemia, 22, 2011, 10.1038/leu.2008.290 · DOI
  4. Eaves, 2015, Hematopoietic stem cells: concepts, definitions, and the new reality, Blood, 125, 2605, 10.1182/blood-2014-12-570200 · DOI
  5. Miller, 2013, Genomic landscapes and clonality of de novo AML, N Engl J Med, 369, 1473
  6. Forbes, 2011, COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer, Nucleic Acids Res, 39, D945, 10.1093/nar/gkq929 · DOI · Paper page
  7. Nice, 2018, Determination of complex subclonal structures of hematological malignancies by multiplexed genotyping of blood progenitor colonies, Exp Hematol, 57, 60, 10.1016/j.exphem.2017.09.011 · DOI
  8. James, 2005, A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera, Nature, 434, 1144, 10.1038/nature03546 · DOI
  9. Kralovics, 2005, A gain of function mutation in Jak2 is frequently found in patients with myeloproliferative disorders, N Engl J Med, 352, 1779, 10.1056/NEJMoa051113 · DOI · Paper page
  10. Levine, 2005, Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis, Cancer Cell, 7, 387, 10.1016/j.ccr.2005.03.023 · DOI · Paper page
  11. Baxter, 2005, Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders, Lancet, 365, 1054, 10.1016/S0140-6736(05)71142-9 · DOI · Paper page
  12. Shih, 2012, The role of mutations in epigenetic regulators in myeloid malignancies, Nat Rev Cancer, 12, 599, 10.1038/nrc3343 · DOI · Paper page
  13. Li, 2011, Mouse models of myeloproliferative neoplasms: JAK of all grades, Dis Model Mech, 4, 311, 10.1242/dmm.006817 · DOI
  14. Mullally, 2012, Myeloproliferative neoplasm animal models, Hematol Oncol Clin North Am, 26, 1065, 10.1016/j.hoc.2012.07.007 · DOI
  15. Hasan, 2013, JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFNα, Blood, 122, 1464, 10.1182/blood-2013-04-498956 · DOI
  16. Mullally, 2013, Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera, Blood, 121, 3692, 10.1182/blood-2012-05-432989 · DOI
  17. Li, 2014, JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease, Blood, 123, 3139, 10.1182/blood-2013-06-510222 · DOI
  18. Ko, 2011, Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice, Proc Natl Acad Sci USA, 108, 14566, 10.1073/pnas.1112317108 · DOI · Paper page
  19. Chen, 2015, Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasms, Blood, 125, 327, 10.1182/blood-2014-04-567024 · DOI
  20. Kameda, 2015, Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator, Blood, 125, 304, 10.1182/blood-2014-04-555508 · DOI
  21. Dykstra, 2007, Long-term propagation of distinct hematopoietic differentiation programs in vivo, Cell Stem Cell, 1, 218, 10.1016/j.stem.2007.05.015 · DOI · Paper page
  22. Kent, 2009, Prospective isolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential, Blood, 113, 6342, 10.1182/blood-2008-12-192054 · DOI
  23. Kent, 2016, Isolation and assessment of single long-term reconstituting hematopoietic stem cells from adult mouse bone marrow, 2A.4.1, 10.1002/cpsc.10 · DOI
  24. Moignard, 2013, Characterization of transcriptional networks in blood stem and progenitor cells using high-throughput single-cell gene expression analysis, Nat Cell Biol, 15, 363, 10.1038/ncb2709 · DOI
  25. Schulte, 2015, Index sorting resolves heterogeneous murine hematopoietic stem cell populations, Exp Hematol, 43, 803, 10.1016/j.exphem.2015.05.006 · DOI
  26. Kent, 2008, Steel factor coordinately regulates the molecular signature and biologic function of hematopoietic stem cells, Blood, 112, 560, 10.1182/blood-2007-10-117820 · DOI
  27. Kent, 2013, Self-renewal of single mouse hematopoietic stem cells is reduced by JAK2V617F without compromising progenitor cell expansion, PLoS Biol, 11, e1001576, 10.1371/journal.pbio.1001576 · DOI
  28. de Haan, 1997, Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity, Blood, 89, 1543, 10.1182/blood.V89.5.1543 · DOI
  29. Mullally, 2010, Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells, Cancer Cell, 17, 584, 10.1016/j.ccr.2010.05.015 · DOI
  30. Iwama, 2004, Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1, Immunity, 21, 843, 10.1016/j.immuni.2004.11.004 · DOI · Paper page
  31. Saudy, 2014, BMI1 gene expression in myeloid leukemias and its impact on prognosis, Blood Cells Mol Dis, 53, 194, 10.1016/j.bcmd.2014.07.002 · DOI
  32. Chowdhury, 2007, Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia, Leukemia, 21, 1116, 10.1038/sj.leu.2404623 · DOI
  33. Mohty, 2007, The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia, Blood, 110, 380, 10.1182/blood-2006-12-065599 · DOI
  34. Mihara, 2006, Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis, Blood, 107, 305, 10.1182/blood-2005-06-2393 · DOI
  35. Hoermann, 2015, Cytokine regulation of microenvironmental cells in myeloproliferative neoplasms, 869242
  36. Abegunde, 2018, An inflammatory environment containing TNFα favors Tet2-mutant clonal hematopoiesis, Exp Hematol, 59, 60, 10.1016/j.exphem.2017.11.002 · DOI · Paper page
  37. Jaiswal, 2014, Age-related clonal hematopoiesis associated with adverse outcomes, N Engl J Med, 371, 2488, 10.1056/NEJMoa1408617 · DOI · Paper page
  38. Wahlestedt, 2017, The slippery slope of hematopoietic stem cell aging, Exp Hematol, 56, 1, 10.1016/j.exphem.2017.09.008 · DOI
  39. Ortmann, 2015, Effect of mutation order on myeloproliferative neoplasms, N Engl J Med, 372, 601, 10.1056/NEJMoa1412098 · DOI · Paper page

Cited by

Metadata

Authors
Shepherd, M. S., Li, J., Wilson, N. K., Oedekoven, C. A., Li, J., Belmonte, M., Fink, J., Prick, J. C. M., Pask, D. C., Hamilton, T. L., Loeffler, D., Rao, A., Schröder, T., Göttgens, B., Green, A. R., & Kent, D. G.
Affiliations
  • Wellcome MRC Cambridge Stem Cell Institute and
  • Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland; and
  • La Jolla Institute and Department of Pharmacology, University of California, San Diego, La Jolla, CA;
ORCID
Venue
Blood
Publisher
American Society of Hematology
Published
2018-08-23
Volume
132
Issue
8
Pages
791-803
ISSN
  • 0006-4971
  • 1528-0020
DOI
10.1182/blood-2017-12-821066
Cited by
33
References
7
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review